Ligand Pharmaceuticals Incorporated (FRA:LGDN)
167.00
-5.00 (-2.91%)
At close: Dec 1, 2025
45.22% (1Y)
| Market Cap | 3.45B |
| Revenue (ttm) | 214.13M |
| Net Income (ttm) | 41.41M |
| Shares Out | n/a |
| EPS (ttm) | 2.12 |
| PE Ratio | 83.29 |
| Forward PE | 29.73 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | n/a |
| Open | 171.00 |
| Previous Close | 172.00 |
| Day's Range | 167.00 - 171.00 |
| 52-Week Range | 86.00 - 181.00 |
| Beta | n/a |
| RSI | 49.18 |
| Earnings Date | Feb 11, 2026 |